knowledge -WSS

knowledge

author：leisure time 2025-09-29 20:51:55 - browse：4332

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： 'Revelatory' study finds a smoking impact that remains after quitting

leisure time

WSS

Swim instructor mom warns parents not to buy blue swimsuits for kids

Doctors' information doesn't help them choose wisely when sick

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Medicare Advantage proposed rates disappoint insurers

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

The dental labor crisis is a moment of opportunity

hotspot

knowledge

focus

How one medical school became remarkably diverse

Why did Pfizer dish out millions for a Super Bowl ad?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How digital tools helped lower hypertension in marginalized patients

BioMarin wins approval for gene therapy to treat hemophilia A

Key House Republican on health care plans exit from Congress

Novavax promises a turnaround & Lilly roils the obesity market

Industry veterans launch new biotech VC with $310M

Wildfire smoke exposes gaps in outdoor worker protections

Presidential fundraising highlights so far: Trump brings in more than DeSantis

focus

Wisconsin governor employs partial veto to fund schools for 4 centuries

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Industry veterans launch new biotech VC with $310M

explore

leisure time

leisure time

hotspot